Evaluation of Mass Drug Administration to Eliminate Lymphatic Filariasis in Surguja and Surajpur District, Chhattisgarh

Simple item page
dc.contributor.authorMendhe, HGen_US
dc.contributor.authorPrasad, MAen_US
dc.contributor.authorPotdar, Pen_US
dc.contributor.authorVerma, A.en_US
dc.date.accessioned2023-08-09T06:11:49Z
dc.date.available2023-08-09T06:11:49Z
dc.date.issued2022-06
dc.description.abstractBackground: Mass Drug Administration of a single dose of DEC was launched on June 5, 2004 by the Government of India. MDA coverage increased gradually from 72.42% in 2004 to 88.96% in 2014. However, compliance has remained relatively low in most of the endemic areas as in 9 endemic Districts in State of Chhattisgarh. In Chhattisgarh State, Lymphatic Filariasis affected 14,818 people in the year 2011 and 13921 in the year 2013 with demonstrated manifestation. Objectives: To assess the coverage and compliance along with factors affecting compliance regarding MDA implementation in Surguja and Surajpur District of Chhattisgarh. Methods: A cross-sectional descriptive study was conducted from July-September 2021 in two district of Chhattisgarh. The division of segments and selection of the households was done based on the WHO criteria of coverage evaluation survey field guide in which from 30 villages, 450 households were covered. Result: The overall coverage rate was 95.55% in Surguja and 89.16% in Surajpur District. The overall compliance was 89.3% with Coverage-Compliance gap of 4.12. The Effective Coverage Rate was 89.3% in 2243 eligible population of Surguja and Surajpur District. Coverage and Compliance was found more in females as compared to males but was found to be statistically not significant. Coverage and Compliance was found more in Surguja district as compared to Surajpur district. Conclusion: Training programme for drug distributors should emphasize more on how to address the fear of side effects among beneficiaries and other reasons of low compliance for the benefit of the MDA programme.en_US
dc.identifier.affiliationsCommunity Medicine, Professor, Department of Community Medicine, Datta Meghe Medical College, Nagpuren_US
dc.identifier.affiliationsCommunity Medicine, Associate Professor, Department of Community Medicine, Shri Balaji Institute of Medical Sciences, Raipur, Chhattisgarhen_US
dc.identifier.affiliationsCommunity Medicine, Assistant Professor, Department of Community medicine, Government Medical College, Ambikapur, Chhattisgarhen_US
dc.identifier.affiliationsDemonstrator, Department of Community medicine, Government Medical College, Ambikapur, Chhattisgarhen_US
dc.identifier.citationMendhe HG, Prasad MA, Potdar P, Verma A.. Evaluation of Mass Drug Administration to Eliminate Lymphatic Filariasis in Surguja and Surajpur District, Chhattisgarh. Indian Journal of Community Health. 2022 Jun; 34(2): 265 – 269en_US
dc.identifier.issn0971-7587
dc.identifier.issn2248-9509
dc.identifier.placeIndiaen_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/221944
dc.languageenen_US
dc.publisherMRI Publication Pvt. Ltd.en_US
dc.relation.issuenumber2en_US
dc.relation.volume34en_US
dc.source.urihttps://doi.org/10.47203/IJCH.2022.v34i02.022en_US
dc.subjectLymphatic Filariasisen_US
dc.subjectMass Drug Administration Complianceen_US
dc.subjectCoverageen_US
dc.titleEvaluation of Mass Drug Administration to Eliminate Lymphatic Filariasis in Surguja and Surajpur District, Chhattisgarhen_US
dc.typeJournal Articleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
IJCH2022v34n2p265.pdf
Size:
675.15 KB
Format:
Adobe Portable Document Format
Download
Collections
Indian Journal of Community Health